Back to all studies
Enrolling By InvitationNCT05427500

5 mL of 0.5% preservative-free bupivacaine for PTSD

This study is enrolling by invitation in Canada. It is testing 5 mL of 0.5% preservative-free bupivacaine for PTSD.

PTSDBehavioralFrom 18 Years to 69 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT05427500. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether 5 mL of 0.5% preservative-free bupivacaine may be useful for adults experiencing ptsd.

What would participation involve?

Participants may receive 5 mL of 0.5% preservative-free bupivacaine, complete questionnaires or follow-up assessments, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Canada.

Who is it mainly for?

This study appears to be mainly for adults with ptsd.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Enrolling By Invitation
Estimated enrollment
54
Sponsor
The Royal's Institute of Mental Health Research
Sponsor type
Research institute
Study type
Behavioral
Intervention type
Medication / drug
Study phase
PHASE3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Canada
Age range
From 18 Years to 69 Years
Official registry ID
NCT05427500
Official title
Stellate Ganglion Block in the Treatment of Posttraumatic Stress Disorder: Outcome Evaluation, Mechanism of Action, and Integration in Care - A Phase III Randomized Controlled Trial
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT05427500. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help test a support approach in real life.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

Based on the public registry summary, this study is trying to understand: The most common treatment for Posttraumatic Stress Disorder (PTSD) is trauma-focused therapy and/or prescription of medication(s). However, these treatments may not directly reduce symptoms associated with PTSD, making it difficult for patients to be treated for this condition. The study team can confirm the exact objective and what it means for you.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study involving 5 mL of 0.5% preservative-free bupivacaine. The listed phase is PHASE3. Ask the study team what that means in practice for safety, monitoring, and criteria.

Do I need to want to stop or reduce tobacco use to participate?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could this study affect my mood, habits, motivation, or stress?

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by The Royal's Institute of Mental Health Research, which appears to be a research institute. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The recruitment status is not clearly listed. Check the official registry or contact the study team. The registry lists an estimated enrollment of 54 participants.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me